Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests. (Q51659423)

9 April 2018

title

Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests. (English)

1 reference

9 April 2018

1 reference

B Meyer-Wyss

1

1 reference

9 April 2018

E Renner

series ordinal

2

1 reference

9 April 2018

H Luo

series ordinal

3

1 reference

9 April 2018

A Scholer

series ordinal

4

1 reference

9 April 2018

publication date

1 August 1993

1 reference

9 April 2018

published in

Journal of Hepatology

1 reference

9 April 2018

volume

19

1 reference

9 April 2018

issue

1

1 reference

9 April 2018

page(s)

133-139

1 reference

9 April 2018

Lignocaine metabolite formation as a measure of pre-transplant liver function.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Assessment of lidocaine metabolite formation as a quantitative liver function test in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Quantitative Assessment of Deranged Hepatic Function: A Missed Opportunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Quantitative Assessment of Hepatic Function by Breath Analysis after Oral Administration of [^14C]aminopyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Aminopyrine breath test predicts surgical risk for patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

The aminopyrine demethylation breath test and the serum bile acid level: nominated but not yet elected to join the common liver tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Prognostic value of the aminopyrine breath test in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Determinants of drug disposition in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

The 30-minute aminopyrine breath test: optimization of sampling times after intravenous administration of 14C-aminopyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: Support for the intact-hepatocyte theory

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Genetic Control of Drug Levels in Man: Antipyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

Galactose elimination capacity as a prognostic index in patients with fulminant liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980186-2

7 January 2021

10.1016/S0168-8278(05)80186-2

Identifiers

DOI

1 reference

9 April 2018

release_hk2tl2ppizhjpfclxw3mtnizqy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hk2tl2ppizhjpfclxw3mtnizqy

24 November 2022

mapped directly with Wikidata item

1 reference

9 April 2018